Now offering Antibiotic susceptibility testing

  • microbroth dilution for cefiderol, meropenem/vaborbactam, imipenem/relebactam and colistin 

  • also available for antifungals and routine gram negative antibiotics

AMR- header IMAGE flattened.no sink lab.png

Clinical Microbiology and Molecular Diagnostics reference laboratory

 
agar plate

ABOUT US

Antimicrobial Resistance Services, the reference laboratory of UVA Health Clinical Microbiology and Molecular Diagnostics, provides advanced environmental microbiology capabilities, whole genome sequencing and a comprehensive bioinformatics pipeline to enhance understanding and to mitigate transmission of bacterial pathogens. 

From sample collection to transmission analysis, we enable our infection prevention and control customers to better understand and to limit hospital acquired infections.

 
Services offered

what SERVICES WE OFFER

mitigate hospital acquired infections

environmental surveillance icon

ENVIRONMENTAL
SURVEILLANCE

We are able to assess the microbiological environment in healthcare facilities and identify risks for transmission of drug-resistant pathogens via premise plumbing sources.

Patient surveillance icon

PATIENT
SURVEILLANCE

We offer culturing of patient perirectal swabs for detection of carbapenemase producing organisms, including identification and determination of genes of drug resistance.

whole genome sequencing icon

WHOLE GENOME
SEQUENCING

Using high-resolution short read whole genome sequencing, we provide within species comparison to understand relatedness of specific strains.

ALREADY A CUSTOMER?

request a consult

Request A CONSULTATION

Infection prevention groups can send us isolates (patient and/or environmental) and we utilize our advanced, high-quality laboratory services and analytics – including Whole Genome Sequencing (WGS) – to answer the following types of questions for you in a timely manner:

 

  • Are these organisms related?

  • Is this infection imported from outside our facility or acquired nosocomially?  What is the potential role of the clinical environment?

  • Has this specific strain of pathogen been seen in our facility before? Is there an issue in our environment that we need to address?

  • How can we identify and manage point sources? How to implement a surveillance program?